“Scientists say they are a step closer to developing a drug to kill the trypanosome parasite that causes human African trypanosomiasis, otherwise known as sleeping sickness, paving the way for a potential cure.”
“The University of York researchers deciphered the mechanism by which the compound, known as AB1 works. AB1 was identified by researchers at the Novartis Institute for Tropical Diseases and similar compounds have been developed as an anti-cancer drug by the company.”
View the whole story here: https://medicalxpress.com/news/2020-07-chemical-treatments-neglected-tropical-diseases.html